Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PET Center Name PET Center Address PET Center Phone and Fax Number Patient Name: Policy Number: Date of Service: To Whom It May Concern: (Insert patient name) is a patient of ours that was diagnosed with Ovarian Cancer in (insert date). Which was treated with a surgical resection and chemotherapy (carboplatin and Taxol). She had a recurrence in (insert year) which was treated with surgery and chemotherapy. In (insert year) she had another recurrence which was treated with chemotherapy and radiation, treatment ended in (insert date) which she then had a PET/CT scan to restage her which was negative for new disease and a good response to the previously noted disease. For follow up in September her CT showed some small lung nodules and a continuing decrease in the pelvic soft tissue mass and some axillary lymphadenopathy. She was scheduled to have a follow up PET/CT in November to characterize the lung nodules and axillary lymphadenopathy as well as determine continued response of chemotherapy in the pelvic mass. (Insert patient name) had her PET/CT on (insert date) to restage her disease and she was found to be free of active disease. Both of her PET/CT scans ((insert date) were helpful in restaging her disease, and should be reconsidered for payment. According to the recent Medicare NOPR study, PET/CT for restaging of ovarian cancer changed management in over 30% of the patients studied, and was the number one cancer entered into the NOPR data. Recent Data from a study performed at (Insert PET Center name) (enclosed) shows the sensitivity of FDG PET/CT for Ovarian Cancer is 88.4% and conventional imaging 75.1%. And a specificity of 88.2% and conventional imaging 64.4% Patients with recurrent ovarian cancer have a higher rate of successful treatments if the cancer is found early and determination of surgery is identified. PET/CT was and is an extremely important imaging modality in making management decisions for ovarian cancer patients. Thank you for your reconsideration in this matter. Thank you for your time and consideration, Sincerely,